Poster
74

Rare CRISPR BCL-2 KO Cells Discovered Using Levitation Technology

Authors

E Diaz-Flores2; S Xirenayi2; J McKinney1; S A Brodie1; P Steinberg1
1 Levitas Bio, United States;  2 University of California San Francisco, Pediatrics Department, United States

Abstract

The use of CRISPR/Cas9 is a key research tool for the study of gene function and role in cancer. In combination with magnetic levitation technology, the ability to enrich for rare genetically modified clones becomes achievable, where it was previously not possible with standard techniques such as cell sorting.

Previously shown, hypodiploid B cell acute lymphoblastic leukemic (B-ALL) cell lines, including the NALM-16 cell line, were highly sensitive to inhibition of BCL-2 by Venetoclax in vitro. However, inhibition of BCL-2 is not complete and residual activity remains present in some cells, leading to therapeutic resistance over time.

In this study using the LeviCell system, we enriched for surviving NALM-16 cells that had BCL-2 knocked out via CRISPR-mediated gene editing. We show here that dead or dying cells post CRISPR modification can mask the ability to effectively identify and isolate surviving clones. Without the use of the LeviCell to quickly and gently enrich these rare surviving cells, these clones would be unavailable for further study.

Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Login
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021